Neurocrine Biosciences, Inc <NBIX.O>: Guggenheim raises target price to $200 from $175
NBIX•Related News
Corsair Gaming director Sarah Mears Kim disposes of 8,874 shares worth $121,474.23
CRSR•
Krystal Biotech Director Dino A. Rossi disposes of USD 8.17 million in common shares
KRYS•
CleanSpark CTO and COO Taylor Monnig disposes of 265 common shares worth $3,050.15
CLSK•
Amazon reinstates binding arbitration, bars class-action lawsuits
AMZN•
Nasdaq Trade Halt Continues <MCTA.O> Reason Not Available at 08:30 PM
MCTA•